Table 3.
cost effectiveness analysis of two different drugs to elimination of H-P in Persian Cohort participants in north-west of Iran, Ardabil 2018-2019
| Cost-Effectiveness | Effect Ratio | Mean Costs | PoTS | NeTS | Total Subjects | |
|---|---|---|---|---|---|---|
| 2,988,488 | 85.93 | 2,570,100 | 867 | 5296 | 6163 | Group A |
| 3,250,170 | 96.54 | 3,120,164 | 46 | 1287 | 1333 | Group B |
NeTS= Negative stool test for H-Pylori, PoTS= Positive stool test for H-Pylori, Effect Ratio= NeTS or PoTS / Total Subject, Cost-Effectiveness= Mean Costs / Effect Ratio
Group A: Amoxicillin 500 + Omeprazole 20 + Bismuth 120 + Furazolidone 100; Group B: Amoxicillin 500 + Omeprazole 20 + Bismuth 120 + Clarithromycin 500